nodes	percent_of_prediction	percent_of_DWPC	metapath
Menadione—MTHFR—uterine cancer	0.378	1	CbGaD
Menadione—NQO1—Carboplatin—uterine cancer	0.136	0.303	CbGbCtD
Menadione—NQO1—Doxorubicin—uterine cancer	0.0781	0.174	CbGbCtD
Menadione—XDH—Carboplatin—uterine cancer	0.0713	0.158	CbGbCtD
Menadione—CYP2A6—Progesterone—uterine cancer	0.0457	0.101	CbGbCtD
Menadione—XDH—Doxorubicin—uterine cancer	0.0408	0.0907	CbGbCtD
Menadione—CYP1A1—Progesterone—uterine cancer	0.039	0.0867	CbGbCtD
Menadione—CYP1A2—Progesterone—uterine cancer	0.0174	0.0387	CbGbCtD
Menadione—CYP2E1—Etoposide—uterine cancer	0.0135	0.03	CbGbCtD
Menadione—F2—posterior vena cava—uterine cancer	0.00996	0.0951	CbGeAlD
Menadione—CYP1A2—Etoposide—uterine cancer	0.0078	0.0173	CbGbCtD
Menadione—F7—artery—uterine cancer	0.00493	0.0471	CbGeAlD
Menadione—Thalidomide—FGFR2—uterine cancer	0.00349	1	CrCbGaD
Menadione—PROZ—renal system—uterine cancer	0.00307	0.0293	CbGeAlD
Menadione—VKORC1—artery—uterine cancer	0.00241	0.023	CbGeAlD
Menadione—F2—artery—uterine cancer	0.00179	0.0171	CbGeAlD
Menadione—MTHFR—artery—uterine cancer	0.00179	0.0171	CbGeAlD
Menadione—F9—epithelium—uterine cancer	0.00179	0.0171	CbGeAlD
Menadione—F7—renal system—uterine cancer	0.00174	0.0166	CbGeAlD
Menadione—VKORC1L1—decidua—uterine cancer	0.00167	0.0159	CbGeAlD
Menadione—F9—renal system—uterine cancer	0.00166	0.0158	CbGeAlD
Menadione—VKORC1L1—renal system—uterine cancer	0.00164	0.0156	CbGeAlD
Menadione—F7—female reproductive system—uterine cancer	0.00139	0.0133	CbGeAlD
Menadione—GGCX—myometrium—uterine cancer	0.00136	0.013	CbGeAlD
Menadione—F9—female reproductive system—uterine cancer	0.00133	0.0127	CbGeAlD
Menadione—VKORC1L1—female reproductive system—uterine cancer	0.00131	0.0125	CbGeAlD
Menadione—PROS1—myometrium—uterine cancer	0.00129	0.0123	CbGeAlD
Menadione—F7—female gonad—uterine cancer	0.00126	0.0121	CbGeAlD
Menadione—F9—female gonad—uterine cancer	0.00121	0.0115	CbGeAlD
Menadione—F9—vagina—uterine cancer	0.0012	0.0115	CbGeAlD
Menadione—VKORC1L1—female gonad—uterine cancer	0.00119	0.0114	CbGeAlD
Menadione—VKORC1L1—vagina—uterine cancer	0.00118	0.0113	CbGeAlD
Menadione—GGCX—uterine cervix—uterine cancer	0.00106	0.0101	CbGeAlD
Menadione—BGLAP—renal system—uterine cancer	0.00101	0.00967	CbGeAlD
Menadione—GGCX—decidua—uterine cancer	0.00101	0.00962	CbGeAlD
Menadione—PROS1—uterine cervix—uterine cancer	0.001	0.00959	CbGeAlD
Menadione—GGCX—renal system—uterine cancer	0.000989	0.00944	CbGeAlD
Menadione—PROS1—decidua—uterine cancer	0.000956	0.00913	CbGeAlD
Menadione—GGCX—endometrium—uterine cancer	0.000956	0.00913	CbGeAlD
Menadione—F10—uterine cervix—uterine cancer	0.000945	0.00902	CbGeAlD
Menadione—PROS1—renal system—uterine cancer	0.000939	0.00897	CbGeAlD
Menadione—GGCX—mammalian vulva—uterine cancer	0.000925	0.00883	CbGeAlD
Menadione—PROS1—endometrium—uterine cancer	0.000908	0.00867	CbGeAlD
Menadione—F10—decidua—uterine cancer	0.0009	0.0086	CbGeAlD
Menadione—GGCX—uterus—uterine cancer	0.000881	0.00841	CbGeAlD
Menadione—PROS1—mammalian vulva—uterine cancer	0.000878	0.00839	CbGeAlD
Menadione—NQO2—myometrium—uterine cancer	0.000862	0.00823	CbGeAlD
Menadione—F10—endometrium—uterine cancer	0.000854	0.00816	CbGeAlD
Menadione—VKORC1—renal system—uterine cancer	0.000847	0.00809	CbGeAlD
Menadione—PROS1—uterus—uterine cancer	0.000837	0.00799	CbGeAlD
Menadione—F10—mammalian vulva—uterine cancer	0.000827	0.00789	CbGeAlD
Menadione—BGLAP—female reproductive system—uterine cancer	0.000811	0.00775	CbGeAlD
Menadione—XDH—uterine cervix—uterine cancer	0.000811	0.00774	CbGeAlD
Menadione—GGCX—female reproductive system—uterine cancer	0.000792	0.00756	CbGeAlD
Menadione—VKORC1L1—lymph node—uterine cancer	0.000766	0.00732	CbGeAlD
Menadione—XDH—renal system—uterine cancer	0.000758	0.00724	CbGeAlD
Menadione—PROS1—female reproductive system—uterine cancer	0.000752	0.00718	CbGeAlD
Menadione—XDH—endometrium—uterine cancer	0.000733	0.007	CbGeAlD
Menadione—NQO1—myometrium—uterine cancer	0.000721	0.00689	CbGeAlD
Menadione—GGCX—female gonad—uterine cancer	0.00072	0.00688	CbGeAlD
Menadione—GGCX—vagina—uterine cancer	0.000716	0.00684	CbGeAlD
Menadione—XDH—mammalian vulva—uterine cancer	0.000709	0.00677	CbGeAlD
Menadione—F10—female reproductive system—uterine cancer	0.000708	0.00676	CbGeAlD
Menadione—PROS1—female gonad—uterine cancer	0.000684	0.00654	CbGeAlD
Menadione—PROS1—vagina—uterine cancer	0.00068	0.0065	CbGeAlD
Menadione—F2—epithelium—uterine cancer	0.000679	0.00648	CbGeAlD
Menadione—VKORC1—female reproductive system—uterine cancer	0.000679	0.00648	CbGeAlD
Menadione—NQO2—uterine cervix—uterine cancer	0.000671	0.00641	CbGeAlD
Menadione—AOX1—myometrium—uterine cancer	0.000662	0.00632	CbGeAlD
Menadione—F10—female gonad—uterine cancer	0.000644	0.00615	CbGeAlD
Menadione—F10—vagina—uterine cancer	0.00064	0.00611	CbGeAlD
Menadione—NQO2—decidua—uterine cancer	0.000639	0.0061	CbGeAlD
Menadione—F2—renal system—uterine cancer	0.00063	0.00601	CbGeAlD
Menadione—NQO2—renal system—uterine cancer	0.000627	0.00599	CbGeAlD
Menadione—VKORC1—female gonad—uterine cancer	0.000617	0.0059	CbGeAlD
Menadione—XDH—female reproductive system—uterine cancer	0.000607	0.0058	CbGeAlD
Menadione—NQO2—endometrium—uterine cancer	0.000607	0.00579	CbGeAlD
Menadione—NQO2—mammalian vulva—uterine cancer	0.000587	0.0056	CbGeAlD
Menadione—NQO1—epithelium—uterine cancer	0.000566	0.00541	CbGeAlD
Menadione—NQO1—uterine cervix—uterine cancer	0.000561	0.00536	CbGeAlD
Menadione—NQO2—uterus—uterine cancer	0.000559	0.00534	CbGeAlD
Menadione—XDH—vagina—uterine cancer	0.000549	0.00525	CbGeAlD
Menadione—NQO1—smooth muscle tissue—uterine cancer	0.000546	0.00521	CbGeAlD
Menadione—NQO1—decidua—uterine cancer	0.000535	0.00511	CbGeAlD
Menadione—NQO1—renal system—uterine cancer	0.000525	0.00502	CbGeAlD
Menadione—AOX1—uterine cervix—uterine cancer	0.000515	0.00492	CbGeAlD
Menadione—MAOB—myometrium—uterine cancer	0.00051	0.00487	CbGeAlD
Menadione—NQO1—endometrium—uterine cancer	0.000508	0.00485	CbGeAlD
Menadione—MTHFR—female reproductive system—uterine cancer	0.000504	0.00482	CbGeAlD
Menadione—F2—female reproductive system—uterine cancer	0.000504	0.00482	CbGeAlD
Menadione—NQO2—female reproductive system—uterine cancer	0.000502	0.0048	CbGeAlD
Menadione—NQO1—mammalian vulva—uterine cancer	0.000491	0.00469	CbGeAlD
Menadione—AOX1—decidua—uterine cancer	0.000491	0.00469	CbGeAlD
Menadione—AOX1—renal system—uterine cancer	0.000482	0.0046	CbGeAlD
Menadione—NQO1—uterus—uterine cancer	0.000468	0.00447	CbGeAlD
Menadione—AOX1—endometrium—uterine cancer	0.000466	0.00445	CbGeAlD
Menadione—GGCX—lymph node—uterine cancer	0.000463	0.00442	CbGeAlD
Menadione—F2—female gonad—uterine cancer	0.000459	0.00438	CbGeAlD
Menadione—MTHFR—female gonad—uterine cancer	0.000459	0.00438	CbGeAlD
Menadione—NQO2—female gonad—uterine cancer	0.000457	0.00437	CbGeAlD
Menadione—NQO2—vagina—uterine cancer	0.000454	0.00434	CbGeAlD
Menadione—AOX1—mammalian vulva—uterine cancer	0.000451	0.0043	CbGeAlD
Menadione—PROS1—lymph node—uterine cancer	0.00044	0.0042	CbGeAlD
Menadione—AOX1—uterus—uterine cancer	0.000429	0.0041	CbGeAlD
Menadione—NQO1—female reproductive system—uterine cancer	0.000421	0.00402	CbGeAlD
Menadione—F10—lymph node—uterine cancer	0.000414	0.00395	CbGeAlD
Menadione—VKORC1—lymph node—uterine cancer	0.000397	0.00379	CbGeAlD
Menadione—MAOB—uterine cervix—uterine cancer	0.000397	0.00379	CbGeAlD
Menadione—AOX1—female reproductive system—uterine cancer	0.000386	0.00369	CbGeAlD
Menadione—NQO1—female gonad—uterine cancer	0.000383	0.00366	CbGeAlD
Menadione—NQO1—vagina—uterine cancer	0.00038	0.00363	CbGeAlD
Menadione—MAOB—decidua—uterine cancer	0.000378	0.00361	CbGeAlD
Menadione—MAOB—renal system—uterine cancer	0.000371	0.00355	CbGeAlD
Menadione—CYP2A6—vagina—uterine cancer	0.000364	0.00348	CbGeAlD
Menadione—MAOB—endometrium—uterine cancer	0.000359	0.00343	CbGeAlD
Menadione—AOX1—female gonad—uterine cancer	0.000351	0.00335	CbGeAlD
Menadione—AOX1—vagina—uterine cancer	0.000349	0.00333	CbGeAlD
Menadione—MAOB—mammalian vulva—uterine cancer	0.000347	0.00332	CbGeAlD
Menadione—MAOB—uterus—uterine cancer	0.000331	0.00316	CbGeAlD
Menadione—MAOB—female reproductive system—uterine cancer	0.000297	0.00284	CbGeAlD
Menadione—MTHFR—lymph node—uterine cancer	0.000295	0.00282	CbGeAlD
Menadione—NQO2—lymph node—uterine cancer	0.000294	0.00281	CbGeAlD
Menadione—CYP1A1—epithelium—uterine cancer	0.000281	0.00268	CbGeAlD
Menadione—CYP1A1—uterine cervix—uterine cancer	0.000279	0.00266	CbGeAlD
Menadione—MAOB—female gonad—uterine cancer	0.000271	0.00258	CbGeAlD
Menadione—MAOB—vagina—uterine cancer	0.000269	0.00257	CbGeAlD
Menadione—CYP1A2—renal system—uterine cancer	0.000264	0.00252	CbGeAlD
Menadione—CYP1A1—renal system—uterine cancer	0.000261	0.00249	CbGeAlD
Menadione—NQO1—lymph node—uterine cancer	0.000246	0.00235	CbGeAlD
Menadione—CYP1A1—mammalian vulva—uterine cancer	0.000244	0.00233	CbGeAlD
Menadione—CYP2E1—renal system—uterine cancer	0.000238	0.00227	CbGeAlD
Menadione—CYP1A1—uterus—uterine cancer	0.000232	0.00222	CbGeAlD
Menadione—AOX1—lymph node—uterine cancer	0.000226	0.00216	CbGeAlD
Menadione—CYP1A1—female reproductive system—uterine cancer	0.000209	0.00199	CbGeAlD
Menadione—CYP2E1—female reproductive system—uterine cancer	0.00019	0.00182	CbGeAlD
Menadione—CYP1A1—female gonad—uterine cancer	0.00019	0.00181	CbGeAlD
Menadione—CYP1A1—vagina—uterine cancer	0.000189	0.0018	CbGeAlD
Menadione—MAOB—lymph node—uterine cancer	0.000174	0.00166	CbGeAlD
Menadione—CYP1A1—lymph node—uterine cancer	0.000122	0.00117	CbGeAlD
Menadione—PROS1—Innate Immune System—NRAS—uterine cancer	3.06e-05	0.00048	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	3.06e-05	0.000478	CbGpPWpGaD
Menadione—PROC—Hemostasis—PIK3CA—uterine cancer	3.04e-05	0.000476	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	3.02e-05	0.000472	CbGpPWpGaD
Menadione—MAOB—Metabolism—DCN—uterine cancer	3e-05	0.00047	CbGpPWpGaD
Menadione—F7—Hemostasis—AKT1—uterine cancer	2.96e-05	0.000464	CbGpPWpGaD
Menadione—PROC—Hemostasis—TP53—uterine cancer	2.94e-05	0.00046	CbGpPWpGaD
Menadione—XDH—Metabolism—AKR1C3—uterine cancer	2.94e-05	0.00046	CbGpPWpGaD
Menadione—F2—Signaling Pathways—RNF43—uterine cancer	2.94e-05	0.00046	CbGpPWpGaD
Menadione—PROS1—Hemostasis—KRAS—uterine cancer	2.93e-05	0.000458	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	2.92e-05	0.000457	CbGpPWpGaD
Menadione—MAOB—Metabolism—CYP11A1—uterine cancer	2.83e-05	0.000443	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.83e-05	0.000443	CbGpPWpGaD
Menadione—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	2.82e-05	0.000441	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—CCL2—uterine cancer	2.82e-05	0.000441	CbGpPWpGaD
Menadione—PROC—Hemostasis—HRAS—uterine cancer	2.81e-05	0.00044	CbGpPWpGaD
Menadione—F2—G alpha (q) signalling events—PIK3CA—uterine cancer	2.8e-05	0.000438	CbGpPWpGaD
Menadione—PROS1—Immune System—CDH1—uterine cancer	2.78e-05	0.000435	CbGpPWpGaD
Menadione—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.78e-05	0.000435	CbGpPWpGaD
Menadione—F10—Hemostasis—EP300—uterine cancer	2.77e-05	0.000434	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—uterine cancer	2.73e-05	0.000427	CbGpPWpGaD
Menadione—MTHFR—Disease—CDKN2B—uterine cancer	2.7e-05	0.000423	CbGpPWpGaD
Menadione—PROS1—Hemostasis—PIK3CA—uterine cancer	2.69e-05	0.000421	CbGpPWpGaD
Menadione—F2—Signaling Pathways—INHBA—uterine cancer	2.69e-05	0.000421	CbGpPWpGaD
Menadione—MAOB—Metabolism—AKR1C3—uterine cancer	2.67e-05	0.000418	CbGpPWpGaD
Menadione—AOX1—Disease—CDKN2B—uterine cancer	2.64e-05	0.000413	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—KRAS—uterine cancer	2.64e-05	0.000413	CbGpPWpGaD
Menadione—F10—Hemostasis—VEGFA—uterine cancer	2.63e-05	0.000411	CbGpPWpGaD
Menadione—PROS1—Hemostasis—TP53—uterine cancer	2.6e-05	0.000407	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.6e-05	0.000406	CbGpPWpGaD
Menadione—F10—Hemostasis—NRAS—uterine cancer	2.59e-05	0.000406	CbGpPWpGaD
Menadione—NQO1—Metabolism—STK11—uterine cancer	2.55e-05	0.0004	CbGpPWpGaD
Menadione—NQO1—Metabolism—CYP19A1—uterine cancer	2.55e-05	0.0004	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—CXCL8—uterine cancer	2.54e-05	0.000398	CbGpPWpGaD
Menadione—MTHFR—Metabolism—STK11—uterine cancer	2.52e-05	0.000395	CbGpPWpGaD
Menadione—MTHFR—Metabolism—CYP19A1—uterine cancer	2.52e-05	0.000395	CbGpPWpGaD
Menadione—CYP1A1—PPARA activates gene expression—EP300—uterine cancer	2.52e-05	0.000394	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—NDUFB11—uterine cancer	2.52e-05	0.000394	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—SRD5A2—uterine cancer	2.52e-05	0.000394	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—uterine cancer	2.5e-05	0.000392	CbGpPWpGaD
Menadione—PROS1—Hemostasis—HRAS—uterine cancer	2.49e-05	0.00039	CbGpPWpGaD
Menadione—PROC—Hemostasis—AKT1—uterine cancer	2.48e-05	0.000389	CbGpPWpGaD
Menadione—MTHFR—Disease—SMAD3—uterine cancer	2.47e-05	0.000386	CbGpPWpGaD
Menadione—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	2.47e-05	0.000386	CbGpPWpGaD
Menadione—AOX1—Metabolism—STK11—uterine cancer	2.46e-05	0.000386	CbGpPWpGaD
Menadione—AOX1—Metabolism—CYP19A1—uterine cancer	2.46e-05	0.000386	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.46e-05	0.000385	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.46e-05	0.000385	CbGpPWpGaD
Menadione—F2—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	2.45e-05	0.000383	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—PIK3CA—uterine cancer	2.42e-05	0.000379	CbGpPWpGaD
Menadione—F2—Signaling Pathways—AKR1C1—uterine cancer	2.42e-05	0.000379	CbGpPWpGaD
Menadione—AOX1—Disease—SMAD3—uterine cancer	2.41e-05	0.000377	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—NDUFB11—uterine cancer	2.37e-05	0.000372	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—SRD5A2—uterine cancer	2.37e-05	0.000372	CbGpPWpGaD
Menadione—MTHFR—Disease—FGFR2—uterine cancer	2.35e-05	0.000368	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—CTNNB1—uterine cancer	2.35e-05	0.000367	CbGpPWpGaD
Menadione—PROS1—Immune System—ERBB2—uterine cancer	2.35e-05	0.000367	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—uterine cancer	2.32e-05	0.000363	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.31e-05	0.000361	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—AKR1B1—uterine cancer	2.3e-05	0.000361	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—STAR—uterine cancer	2.3e-05	0.000361	CbGpPWpGaD
Menadione—AOX1—Disease—FGFR2—uterine cancer	2.3e-05	0.000359	CbGpPWpGaD
Menadione—XDH—Metabolism—CYP19A1—uterine cancer	2.29e-05	0.000358	CbGpPWpGaD
Menadione—XDH—Metabolism—STK11—uterine cancer	2.29e-05	0.000358	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—HRAS—uterine cancer	2.24e-05	0.000351	CbGpPWpGaD
Menadione—F10—Hemostasis—KRAS—uterine cancer	2.23e-05	0.000349	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—CXCL8—uterine cancer	2.23e-05	0.000348	CbGpPWpGaD
Menadione—AOX1—Disease—MTHFR—uterine cancer	2.21e-05	0.000346	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.21e-05	0.000346	CbGpPWpGaD
Menadione—PROS1—Hemostasis—AKT1—uterine cancer	2.2e-05	0.000344	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.18e-05	0.000341	CbGpPWpGaD
Menadione—PROS1—Immune System—CDKN1B—uterine cancer	2.17e-05	0.00034	CbGpPWpGaD
Menadione—MAOB—Metabolism—CYP19A1—uterine cancer	2.08e-05	0.000326	CbGpPWpGaD
Menadione—MAOB—Metabolism—STK11—uterine cancer	2.08e-05	0.000326	CbGpPWpGaD
Menadione—PROS1—Immune System—CTNNB1—uterine cancer	2.05e-05	0.000321	CbGpPWpGaD
Menadione—F10—Hemostasis—PIK3CA—uterine cancer	2.05e-05	0.000321	CbGpPWpGaD
Menadione—F2—Platelet activation, signaling and aggregation—AKT1—uterine cancer	2e-05	0.000313	CbGpPWpGaD
Menadione—PROS1—Immune System—PTEN—uterine cancer	2e-05	0.000313	CbGpPWpGaD
Menadione—F10—Hemostasis—TP53—uterine cancer	1.98e-05	0.00031	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—CCL2—uterine cancer	1.98e-05	0.00031	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—AKT1—uterine cancer	1.98e-05	0.00031	CbGpPWpGaD
Menadione—NQO1—Metabolism—MTHFR—uterine cancer	1.92e-05	0.0003	CbGpPWpGaD
Menadione—PROS1—Immune System—EP300—uterine cancer	1.91e-05	0.000299	CbGpPWpGaD
Menadione—F10—Hemostasis—HRAS—uterine cancer	1.9e-05	0.000297	CbGpPWpGaD
Menadione—F2—Signaling Pathways—AKR1C3—uterine cancer	1.86e-05	0.000292	CbGpPWpGaD
Menadione—AOX1—Metabolism—MTHFR—uterine cancer	1.85e-05	0.00029	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—AKR1B1—uterine cancer	1.82e-05	0.000285	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—STAR—uterine cancer	1.82e-05	0.000285	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PGR—uterine cancer	1.82e-05	0.000284	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—POLD1—uterine cancer	1.81e-05	0.000283	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.8e-05	0.000282	CbGpPWpGaD
Menadione—PROS1—Immune System—NRAS—uterine cancer	1.78e-05	0.000279	CbGpPWpGaD
Menadione—F2—Signaling Pathways—YWHAE—uterine cancer	1.73e-05	0.000271	CbGpPWpGaD
Menadione—XDH—Metabolism—MTHFR—uterine cancer	1.72e-05	0.000269	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—AKR1B1—uterine cancer	1.72e-05	0.000269	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—STAR—uterine cancer	1.72e-05	0.000269	CbGpPWpGaD
Menadione—F2—Hemostasis—EP300—uterine cancer	1.71e-05	0.000267	CbGpPWpGaD
Menadione—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	1.7e-05	0.000266	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.7e-05	0.000266	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—AKR1C1—uterine cancer	1.69e-05	0.000265	CbGpPWpGaD
Menadione—F10—Hemostasis—AKT1—uterine cancer	1.68e-05	0.000262	CbGpPWpGaD
Menadione—F2—Signaling Pathways—FBXW7—uterine cancer	1.66e-05	0.00026	CbGpPWpGaD
Menadione—F2—Hemostasis—VEGFA—uterine cancer	1.62e-05	0.000253	CbGpPWpGaD
Menadione—F2—Hemostasis—NRAS—uterine cancer	1.6e-05	0.00025	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—CXCL8—uterine cancer	1.57e-05	0.000245	CbGpPWpGaD
Menadione—MAOB—Metabolism—MTHFR—uterine cancer	1.56e-05	0.000245	CbGpPWpGaD
Menadione—PROS1—Immune System—KRAS—uterine cancer	1.54e-05	0.00024	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.51e-05	0.000237	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.51e-05	0.000237	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—RRM2—uterine cancer	1.51e-05	0.000236	CbGpPWpGaD
Menadione—MTHFR—Disease—ERBB2—uterine cancer	1.48e-05	0.000231	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.47e-05	0.00023	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—DCN—uterine cancer	1.46e-05	0.000229	CbGpPWpGaD
Menadione—F2—Signaling Pathways—STK11—uterine cancer	1.45e-05	0.000227	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—CCL2—uterine cancer	1.45e-05	0.000226	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—CTNNB1—uterine cancer	1.44e-05	0.000226	CbGpPWpGaD
Menadione—AOX1—Disease—ERBB2—uterine cancer	1.44e-05	0.000226	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—POLD1—uterine cancer	1.43e-05	0.000224	CbGpPWpGaD
Menadione—PROS1—Immune System—PIK3CA—uterine cancer	1.41e-05	0.000221	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.39e-05	0.000217	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CYP11A1—uterine cancer	1.38e-05	0.000216	CbGpPWpGaD
Menadione—F2—Hemostasis—KRAS—uterine cancer	1.37e-05	0.000215	CbGpPWpGaD
Menadione—MTHFR—Disease—CDKN1B—uterine cancer	1.37e-05	0.000214	CbGpPWpGaD
Menadione—F2—Signaling Pathways—SOCS3—uterine cancer	1.36e-05	0.000213	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—POLD1—uterine cancer	1.35e-05	0.000211	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—AKR1C1—uterine cancer	1.34e-05	0.000209	CbGpPWpGaD
Menadione—AOX1—Disease—CDKN1B—uterine cancer	1.34e-05	0.000209	CbGpPWpGaD
Menadione—PROS1—Immune System—HRAS—uterine cancer	1.31e-05	0.000204	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—AKR1C3—uterine cancer	1.3e-05	0.000204	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CDKN2B—uterine cancer	1.3e-05	0.000204	CbGpPWpGaD
Menadione—MTHFR—Disease—CTNNB1—uterine cancer	1.29e-05	0.000202	CbGpPWpGaD
Menadione—F2—Signaling Pathways—IGF1R—uterine cancer	1.26e-05	0.000198	CbGpPWpGaD
Menadione—F2—Hemostasis—PIK3CA—uterine cancer	1.26e-05	0.000198	CbGpPWpGaD
Menadione—AOX1—Disease—CTNNB1—uterine cancer	1.26e-05	0.000197	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—AKR1C1—uterine cancer	1.26e-05	0.000197	CbGpPWpGaD
Menadione—MTHFR—Disease—PTEN—uterine cancer	1.26e-05	0.000197	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—CXCL8—uterine cancer	1.26e-05	0.000197	CbGpPWpGaD
Menadione—AOX1—Disease—PTEN—uterine cancer	1.23e-05	0.000192	CbGpPWpGaD
Menadione—F2—Hemostasis—TP53—uterine cancer	1.22e-05	0.000191	CbGpPWpGaD
Menadione—MTHFR—Disease—EP300—uterine cancer	1.2e-05	0.000188	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—RRM2—uterine cancer	1.19e-05	0.000186	CbGpPWpGaD
Menadione—F2—Signaling Pathways—SMAD3—uterine cancer	1.19e-05	0.000186	CbGpPWpGaD
Menadione—AOX1—Disease—EP300—uterine cancer	1.17e-05	0.000184	CbGpPWpGaD
Menadione—F2—Hemostasis—HRAS—uterine cancer	1.17e-05	0.000183	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—DCN—uterine cancer	1.16e-05	0.000181	CbGpPWpGaD
Menadione—PROS1—Immune System—AKT1—uterine cancer	1.15e-05	0.00018	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—CXCL8—uterine cancer	1.14e-05	0.000179	CbGpPWpGaD
Menadione—F2—Signaling Pathways—FGFR2—uterine cancer	1.13e-05	0.000177	CbGpPWpGaD
Menadione—MTHFR—Disease—NRAS—uterine cancer	1.12e-05	0.000176	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—RRM2—uterine cancer	1.12e-05	0.000176	CbGpPWpGaD
Menadione—AOX1—Disease—NRAS—uterine cancer	1.1e-05	0.000172	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.09e-05	0.000171	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—STAR—uterine cancer	1.09e-05	0.000171	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—DCN—uterine cancer	1.09e-05	0.000171	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.09e-05	0.00017	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.08e-05	0.000169	CbGpPWpGaD
Menadione—NQO1—Metabolism—PTEN—uterine cancer	1.07e-05	0.000167	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PTEN—uterine cancer	1.05e-05	0.000165	CbGpPWpGaD
Menadione—F2—Hemostasis—AKT1—uterine cancer	1.03e-05	0.000161	CbGpPWpGaD
Menadione—AOX1—Metabolism—PTEN—uterine cancer	1.03e-05	0.000161	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.03e-05	0.000161	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CYP11A1—uterine cancer	1.03e-05	0.000161	CbGpPWpGaD
Menadione—NQO1—Metabolism—EP300—uterine cancer	1.02e-05	0.000159	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—STK11—uterine cancer	1.01e-05	0.000159	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.01e-05	0.000159	CbGpPWpGaD
Menadione—MTHFR—Metabolism—EP300—uterine cancer	1.01e-05	0.000157	CbGpPWpGaD
Menadione—AOX1—Metabolism—EP300—uterine cancer	9.82e-06	0.000154	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—AKR1C3—uterine cancer	9.7e-06	0.000152	CbGpPWpGaD
Menadione—F2—Signaling Pathways—ESR1—uterine cancer	9.7e-06	0.000152	CbGpPWpGaD
Menadione—MTHFR—Disease—KRAS—uterine cancer	9.67e-06	0.000151	CbGpPWpGaD
Menadione—XDH—Metabolism—PTEN—uterine cancer	9.58e-06	0.00015	CbGpPWpGaD
Menadione—AOX1—Disease—KRAS—uterine cancer	9.45e-06	0.000148	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—NRAS—uterine cancer	9.17e-06	0.000143	CbGpPWpGaD
Menadione—XDH—Metabolism—EP300—uterine cancer	9.13e-06	0.000143	CbGpPWpGaD
Menadione—MTHFR—Disease—PIK3CA—uterine cancer	8.88e-06	0.000139	CbGpPWpGaD
Menadione—MAOB—Metabolism—PTEN—uterine cancer	8.7e-06	0.000136	CbGpPWpGaD
Menadione—AOX1—Disease—PIK3CA—uterine cancer	8.68e-06	0.000136	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—POLD1—uterine cancer	8.59e-06	0.000134	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CCL2—uterine cancer	8.54e-06	0.000134	CbGpPWpGaD
Menadione—MAOB—Metabolism—EP300—uterine cancer	8.3e-06	0.00013	CbGpPWpGaD
Menadione—MTHFR—Disease—HRAS—uterine cancer	8.22e-06	0.000129	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—AKR1C1—uterine cancer	8.03e-06	0.000126	CbGpPWpGaD
Menadione—AOX1—Disease—HRAS—uterine cancer	8.03e-06	0.000126	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—STK11—uterine cancer	8.02e-06	0.000125	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CYP19A1—uterine cancer	8.02e-06	0.000125	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—PIK3CA—uterine cancer	7.98e-06	0.000125	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—KRAS—uterine cancer	7.89e-06	0.000123	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—MTHFR—uterine cancer	7.62e-06	0.000119	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CYP19A1—uterine cancer	7.56e-06	0.000118	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—STK11—uterine cancer	7.56e-06	0.000118	CbGpPWpGaD
Menadione—NQO1—Metabolism—PIK3CA—uterine cancer	7.53e-06	0.000118	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PIK3CA—uterine cancer	7.44e-06	0.000116	CbGpPWpGaD
Menadione—AOX1—Metabolism—PIK3CA—uterine cancer	7.27e-06	0.000114	CbGpPWpGaD
Menadione—MTHFR—Disease—AKT1—uterine cancer	7.26e-06	0.000114	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—PIK3CA—uterine cancer	7.25e-06	0.000113	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—RRM2—uterine cancer	7.16e-06	0.000112	CbGpPWpGaD
Menadione—F2—Signaling Pathways—ERBB2—uterine cancer	7.12e-06	0.000111	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.09e-06	0.000111	CbGpPWpGaD
Menadione—AOX1—Disease—AKT1—uterine cancer	7.09e-06	0.000111	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—DCN—uterine cancer	6.95e-06	0.000109	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.77e-06	0.000106	CbGpPWpGaD
Menadione—XDH—Metabolism—PIK3CA—uterine cancer	6.76e-06	0.000106	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CXCL8—uterine cancer	6.75e-06	0.000106	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HRAS—uterine cancer	6.71e-06	0.000105	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CDKN1B—uterine cancer	6.59e-06	0.000103	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CYP11A1—uterine cancer	6.55e-06	0.000102	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—AKT1—uterine cancer	6.52e-06	0.000102	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CTNNB1—uterine cancer	6.23e-06	9.74e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—AKR1C3—uterine cancer	6.19e-06	9.68e-05	CbGpPWpGaD
Menadione—NQO1—Metabolism—AKT1—uterine cancer	6.15e-06	9.63e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—PIK3CA—uterine cancer	6.14e-06	9.61e-05	CbGpPWpGaD
Menadione—MTHFR—Metabolism—AKT1—uterine cancer	6.08e-06	9.51e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PTEN—uterine cancer	6.07e-06	9.5e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—MTHFR—uterine cancer	6.02e-06	9.42e-05	CbGpPWpGaD
Menadione—AOX1—Metabolism—AKT1—uterine cancer	5.94e-06	9.29e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—AKT1—uterine cancer	5.92e-06	9.26e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—EP300—uterine cancer	5.79e-06	9.06e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—MTHFR—uterine cancer	5.68e-06	8.89e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—AKT1—uterine cancer	5.52e-06	8.64e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—VEGFA—uterine cancer	5.48e-06	8.58e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NRAS—uterine cancer	5.41e-06	8.47e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—AKT1—uterine cancer	5.02e-06	7.85e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5e-06	7.83e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—STK11—uterine cancer	4.82e-06	7.54e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CYP19A1—uterine cancer	4.82e-06	7.54e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—KRAS—uterine cancer	4.66e-06	7.29e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.52e-06	7.08e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.31e-06	6.75e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PIK3CA—uterine cancer	4.28e-06	6.7e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PTEN—uterine cancer	4.24e-06	6.63e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TP53—uterine cancer	4.14e-06	6.48e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—EP300—uterine cancer	4.04e-06	6.33e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HRAS—uterine cancer	3.96e-06	6.2e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—MTHFR—uterine cancer	3.62e-06	5.67e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—AKT1—uterine cancer	3.5e-06	5.47e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PTEN—uterine cancer	3.35e-06	5.24e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—EP300—uterine cancer	3.2e-06	5e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.19e-06	4.99e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PTEN—uterine cancer	3.16e-06	4.94e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—EP300—uterine cancer	3.01e-06	4.71e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PIK3CA—uterine cancer	2.99e-06	4.68e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—AKT1—uterine cancer	2.44e-06	3.82e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PIK3CA—uterine cancer	2.36e-06	3.7e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PIK3CA—uterine cancer	2.23e-06	3.49e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PTEN—uterine cancer	2.01e-06	3.15e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—AKT1—uterine cancer	1.93e-06	3.02e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—EP300—uterine cancer	1.92e-06	3.01e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—AKT1—uterine cancer	1.82e-06	2.85e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.42e-06	2.22e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—AKT1—uterine cancer	1.16e-06	1.82e-05	CbGpPWpGaD
